IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S: Financial statements 2013
CVR: 16584037
Source: annual report 2013, Danish Business Authority
01/04/2012 – 31/03/2013
IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S (CVR 16584037) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 11,748,880 and a net result of DKK 7,119,974. Equity in the 2013 report amounted to DKK 69,529,409. The solvency ratio was 97.3%.
- Gross Profit
- DKK 11,748,880
- Profit/Loss
- DKK 7,119,974
- Equity
- DKK 69,529,409
- Total Assets
- DKK 71,485,411
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of July 19, 2013, JUT NR. 2180 A/S has been appointed auditor of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
As of July 18, 2013, DANSK REVISION ROSKILDE, GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
As of March 27, 2013, Christopher Henry Francis Yates has joined the board of directors of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
As of March 27, 2013, Rudolf Joachim Schemer has joined the board of directors of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
As of March 27, 2013, Roger Thomas Patrick Duggan has left the board of directors of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
As of March 27, 2013, Antony William Wilks has left the board of directors of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
As of March 27, 2013, Patrik Olof Dahlén is registered as chairman of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
As of March 27, 2013, Rudolf Joachim Schemer is registered as adm. dir of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
As of March 27, 2013, Paul Hailes has stepped down as chairman of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
As of March 27, 2013, Roger Thomas Patrick Duggan has stepped down as direktion of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
About IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S
IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S was a Danish company of the type Aktieselskab based in København S, founded in 1992. The company has been dissolved on 11 October 2019. The company was registered under the industry Engroshandel med kemiske produkter. The company was previously named NORDIC BIOSCIENCE DIAGNOSTICS A/S and OSTEOMETER BIOTECH A/S. The company has 1 employee (2018). In 2019, the company reported a gross profit of DKK 877,018 and a net result of DKK 1,209,814 compared with DKK 5,073,540 the year before. Equity in the 2019 report amounted to DKK 102,384,800.
